365 related articles for article (PubMed ID: 21852570)
1. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
[TBL] [Abstract][Full Text] [Related]
2. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
3. Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters.
Ma W; Li N; Zhao W; Ren J; Wei M; Yang Y; Wang Y; Fu X; Zhang Z; Larson AC; Huan Y
J Comput Assist Tomogr; 2016; 40(5):709-16. PubMed ID: 27224231
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
Huang W; Tudorica LA; Li X; Thakur SB; Chen Y; Morris EA; Tagge IJ; Korenblit ME; Rooney WD; Koutcher JA; Springer CS
Radiology; 2011 Nov; 261(2):394-403. PubMed ID: 21828189
[TBL] [Abstract][Full Text] [Related]
5. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
[TBL] [Abstract][Full Text] [Related]
6. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
9. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
[TBL] [Abstract][Full Text] [Related]
10. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
Breault SR; Heye T; Bashir MR; Dale BM; Merkle EM; Reiner CS; Faridi KF; Gupta RT
AJR Am J Roentgenol; 2013 Mar; 200(3):W297-303. PubMed ID: 23436875
[TBL] [Abstract][Full Text] [Related]
14. Correlation between pancreatic microcirculation and type 2 diabetes in patients with coronary artery disease: dynamic contrast-enhanced MR imaging.
Yu CW; Shih TT; Hsu CY; Lin LC; Wei SY; Lee CM; Lee YT
Radiology; 2009 Sep; 252(3):704-11. PubMed ID: 19717751
[TBL] [Abstract][Full Text] [Related]
15. B
Tsai WC; Kao KJ; Chang KM; Hung CF; Yang Q; Lin CE; Chen CM
Radiology; 2017 Jan; 282(1):55-62. PubMed ID: 27479805
[TBL] [Abstract][Full Text] [Related]
16. Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
Coolen J; De Keyzer F; Nafteux P; De Wever W; Dooms C; Vansteenkiste J; Roebben I; Verbeken E; De Leyn P; Van Raemdonck D; Nackaerts K; Dymarkowski S; Verschakelen J
Radiology; 2012 Jun; 263(3):884-92. PubMed ID: 22535562
[TBL] [Abstract][Full Text] [Related]
17. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.
Cho N; Im SA; Park IA; Lee KH; Li M; Han W; Noh DY; Moon WK
Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612
[TBL] [Abstract][Full Text] [Related]
19. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Stephan C; Taupitz M; Beyersdorff D
Radiology; 2009 Jul; 252(1):101-8. PubMed ID: 19561252
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
